Published by Michele Maatouk on 8th June 2026
(Sharecast News) - Shares of Zealand Pharma tumbled on Monday after the Danish pharmaceutical group said one in five patients dropped out of a trial of Boehringer Ingelheim's experimental survodutide obesity drug due to gastrointestinal side effects.
URL: http://www.digitallook.com/dl/news/story/35984926/...